Overview of therapeutic and disease areas

UCB has created two divisions to focus on severe diseases treated by specialists, covering two main therapeutic areas: central nervous system (CNS) disorders and immunology diseases.

In addition to its clinical development pipeline, UCB has a number of molecules in late stage research or pre-clinical development.